Rincon Bio performs SKM-1 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
SKM-1 cells were derived from a 76 year old male with Acute Myeloid Leukemia
Homozygous for KRAS
Homozygous for TP53
Used in xenografts to test the efficacy of novel cancer therapeutics.
Rincon Bio Growth Curve
Cell Line: SKM-1
Mouse Strain: NOD/SCID-gamma
Cells Implanted per Animal: 10 million
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.